Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galectin Therapeutics Inc. (GALT)

3.4   0.07 (2.1%) 08-16 16:00
Open: 3.36 Pre. Close: 3.33
High: 3.4825 Low: 3.3
Volume: 139,201 Market Cap: 193M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.482 - 3.503 3.503 - 3.523
Low: 3.252 - 3.276 3.276 - 3.299
Close: 3.363 - 3.399 3.399 - 3.433

Technical analysis

as of: 2019-08-16 4:48:32 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.33     One year: 4.72
Support: Support1: 3.16    Support2: 2.63
Resistance: Resistance1: 3.70    Resistance2: 4.04
Pivot: 3.47
Moving Average: MA(5): 3.43     MA(20): 3.57
MA(100): 4.14     MA(250): 4.62
MACD: MACD(12,26): -0.14     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 26.91     %D(3): 30.87
RSI: RSI(14): 41.77
52-week: High: 6.98  Low: 3.16  Change(%): -12.1
Average Vol(K): 3-Month: 34808  10-Days: 30260

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GALT has closed above bottom band by 39.1%. Bollinger Bands are 1.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 07 Aug 2019 17:10:25 Z
Endo (ENDP) Q2 Earnings & Revenues Beat Estimates, Down Y/Y

Wed, 07 Aug 2019 17:08:09 Z
Bausch (BHC) Misses on Q2 Earnings & Sales, Raises View

Tue, 06 Aug 2019 17:12:01 Z
Zoetis (ZTS) Beats on Earnings in Q2, Lifts 2019 Guidance

Wed, 13 Feb 2019 22:37:03 Z
Conatus (CNAT) Completes Enrollment in Phase II NASH Study

Wed, 13 Feb 2019 16:44:52 Z
Ascendis Pharma Files IND for Hypoparathyroidism Candidate

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 37.57
Shares Float (M) 32.88
% Held by Insiders 24.55
% Held by Institutions 12.63
Shares Short (K) 3710
Shares Short P. Month (K)

Stock Financials

EPS -0.474
EPS Est. Current Year -0.530
EPS Est. Next Year -0.520
EPS Est. Next Quarter -0.130
Forward EPS -0.690
Book Value (p.s.) 0.100
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -115.5
Return on Equity (ttm) -253.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -9.95
Levered Free Cash Flow (M) -5.09

Stock Valuations

P/E -7.17
P/E Growth Ratio 0.02
P/BV 34.00
P/S
P/CF -12.84

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2012-03-23
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.